Reduction of salivary flow in amyotrophic lateral sclerosis with Scopoderm TTS.
Talmi
Y P
YP
Finkelstein
Y
Y
Zohar
Y
Y
D000279:Administration, Cutaneous; D000690:Amyotrophic Lateral Sclerosis / Q000150:complications* / Q000628:therapy; D006801:Humans; D012601:Scopolamine / Q000008:administration & dosage* / Q000627:therapeutic use; D012798:Sialorrhea / Q000188:drug therapy* / Q000209:etiology
D012601:Scopolamine